Acquisition and Rebranding
Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio
AcuraBio
PR-M09-22-01Sep 07, 2022
mRNA Manufacturing
Vernal Biosciences Raises $21 Million to Accelerate mRNA Manufacturing Growth
Vernal Biosciences
PR-M06-22-01-351Jun 02, 2022
CDMO Acquisition
Vibalogics Acquired by Top Global CDMO Recipharm AB
Vibalogics
PR-M02-22-18Feb 18, 2022
Investment
Investing at the Intersection of Industrial Manufacturing and Healthcare
David Q. Anderson
Ampersand Capital Partners
PAP-Q2-20-CL-025Jul 01, 2020
Meet the Investor
Selecting the Right Private Equity Partner to Build a Leading Outsourcing Provider
David Q. Anderson
Ampersand Capital Partners
PAP-Q1-2019-CL-024Mar 12, 2019